DISCOUNT OPTIONSSCHEIN - ABBVIE Share Price

Certificat

DE000ME88XM4

Market Closed - Börse Stuttgart 11:57:49 17/05/2024 pm IST
0.97 EUR +7.78% Intraday chart for DISCOUNT OPTIONSSCHEIN - ABBVIE
Current month-3.00%
1 month-19.17%
Date Price Change
17/24/17 0.97 +7.78%
16/24/16 0.9 -2.17%
15/24/15 0.92 +6.98%
14/24/14 0.86 -2.27%
13/24/13 0.88 -1.12%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 11:57 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ABBVIE INC.
Issuer Morgan Stanley
WKN ME88XM
ISINDE000ME88XM4
Date issued 06/02/2024
Strike 210 $
Maturity 20/12/2024 (217 Days)
Parity 1 : 1
Emission price 0.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.51
Lowest since issue 0.78
Spread 0.05
Spread %4.90%

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
166.4 USD
Average target price
182.3 USD
Spread / Average Target
+9.52%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW